Growing optimism and a £2bn investor payout is a shot in the arm for this British giant
Last week’s full-year results from GlaxoSmithKline (GSK) do not answer every concern the sceptics may have regarding current ...
CSL shares push higher despite 'mixed result with headline misses'
There were positives and negatives in the company's first half performance. The post CSL shares push higher despite 'mixed ...
TMCnet18h
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages GSK plc. (GSK) Investors To Inquire About Securities Fraud Class Action
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise ...
BioPharma Dive3d
Pfizer taps former Novartis exec to lead cancer drug push
The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...
When the Cost of His Asthma Inhaler Went Up $500, His Parents Claim He Couldn't Pay. Two Weeks Later He Was Dead at 22
Cole Schmidtknecht, 22, couldn't pay for his daily inhaler due to the “prohibitively expensive” price increase. Two weeks ...
Arizona says GlaxoSmithKline's greed endangered kids with asthma
GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...
GSK Reported Strong Earnings, So I Reiterate My Strong Buy
GSK, a UK-based biopharma, reported strong 2024 results, with a promising shift toward specialty medicines. Read why I ...
Previewing Kansas City's Super Bowl LIX game vs. Eagles on Chiefs Wire Podcast
Senior Writer Ed Easton Jr. spoke to four-time Super Bowl champion Rob Gronkowski. He reflected on his Tampa Bay Buccaneers’ ...
TMCnet5d
GSK plc. (GSK) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN GSK PLC. (GSK), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.
GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 Billion
GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...
BioPharma Dive5d
GSK, Pfizer sales of RSV shots slow as vaccination rates ebb
Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...
GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share Buyback Plan
GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of optimism about sales of its new drugs ...